Healthcare

The telehealth provider Hims & Hers finds itself navigating turbulent market conditions. Despite management's confident move to authorize a substantial...

ResMed's latest quarterly earnings have painted a complex picture for investors. The medical technology specialist delivered fundamentally strong results, yet...

UnitedHealth Group's recent appointment of former FDA commissioner Scott Gottlieb to its board of directors has generated a surprising market...

A significant vote of confidence has been placed in Redcare Pharmacy, not through words, but through a substantial financial commitment....

Redcare Pharmacy is making a strategic leadership move by appointing an Amazon finance veteran as its new Chief Financial Officer....

UnitedHealth Group has made a strategic addition to its board of directors, bringing in former U.S. Food and Drug Administration...

As investors question whether Palantir's recent stock weakness represents a temporary pause or the beginning of a broader correction, the...

Intellia Therapeutics captured significant market attention on November 16 when the biotechnology firm unveiled groundbreaking clinical trial data for its...

The telehealth sector's rising star, Hims & Hers, has made a dramatic move to demonstrate faith in its own valuation,...

Monday's trading session revealed unusual quiet for healthcare giant UnitedHealth, signaling potential concerns for market participants. The insurance behemoth, typically...